ATE101132T1 - 1-((diarylmethoxy)alkyl>-pyrrolidine und piperidine, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten. - Google Patents

1-((diarylmethoxy)alkyl>-pyrrolidine und piperidine, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.

Info

Publication number
ATE101132T1
ATE101132T1 AT89402561T AT89402561T ATE101132T1 AT E101132 T1 ATE101132 T1 AT E101132T1 AT 89402561 T AT89402561 T AT 89402561T AT 89402561 T AT89402561 T AT 89402561T AT E101132 T1 ATE101132 T1 AT E101132T1
Authority
AT
Austria
Prior art keywords
diarylmethoxy
pyrrolidine
piperidine
alkyl
preparation
Prior art date
Application number
AT89402561T
Other languages
English (en)
Inventor
Gerard Ferrand
Jacques Barbanton
Jean-Claude Depin
Gilles Chavernac
Original Assignee
Lipha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lipha filed Critical Lipha
Application granted granted Critical
Publication of ATE101132T1 publication Critical patent/ATE101132T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • H—ELECTRICITY
    • H03—ELECTRONIC CIRCUITRY
    • H03H—IMPEDANCE NETWORKS, e.g. RESONANT CIRCUITS; RESONATORS
    • H03H7/00—Multiple-port networks comprising only passive electrical elements as network components
    • H03H7/01—Frequency selective two-port networks
    • H03H7/09—Filters comprising mutual inductance

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
AT89402561T 1988-09-23 1989-09-19 1-((diarylmethoxy)alkyl>-pyrrolidine und piperidine, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten. ATE101132T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8812430A FR2636946B1 (fr) 1988-09-23 1988-09-23 ((diarylmethoxy)alcoyl)-1 pyrrolidines et piperidines, procedes de preparation et medicaments les contenant
EP89402561A EP0360685B1 (de) 1988-09-23 1989-09-19 1-[(Diarylmethoxy)alkyl]-pyrrolidine und -piperidine, Verfahren zu ihrer Herstellung und Arzneimittel, die sie enthalten

Publications (1)

Publication Number Publication Date
ATE101132T1 true ATE101132T1 (de) 1994-02-15

Family

ID=9370298

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89402561T ATE101132T1 (de) 1988-09-23 1989-09-19 1-((diarylmethoxy)alkyl>-pyrrolidine und piperidine, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.

Country Status (25)

Country Link
US (1) US4957927A (de)
EP (1) EP0360685B1 (de)
JP (1) JPH02121964A (de)
AR (1) AR246255A1 (de)
AT (1) ATE101132T1 (de)
AU (1) AU617530B2 (de)
CA (1) CA1327364C (de)
CZ (1) CZ279282B6 (de)
DD (1) DD284875A5 (de)
DE (1) DE68912860T2 (de)
DK (1) DK468389A (de)
ES (1) ES2062071T3 (de)
FR (1) FR2636946B1 (de)
HU (1) HU208422B (de)
IE (1) IE63648B1 (de)
IL (1) IL91689A0 (de)
MA (1) MA21631A1 (de)
NO (1) NO893764L (de)
NZ (1) NZ230744A (de)
OA (1) OA09135A (de)
PT (1) PT91783B (de)
SU (1) SU1757462A3 (de)
TN (1) TNSN89103A1 (de)
YU (1) YU170189A (de)
ZA (1) ZA897212B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9100517A (es) * 1990-08-06 1992-04-01 Smith Kline French Lab Compuestos
IE912759A1 (en) * 1990-08-06 1992-02-12 Smith Kline French Lab Compounds
TW230771B (de) * 1990-08-09 1994-09-21 Sankyo Co
GB9113031D0 (en) * 1991-06-17 1991-08-07 Smithkline Beecham Plc Compounds
US5578639A (en) * 1994-07-01 1996-11-26 Warner-Lambert Company PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US6201124B1 (en) 1995-12-21 2001-03-13 Albany Molecular Research, Inc. Process for production of piperidine derivatives
US5747523A (en) * 1996-01-24 1998-05-05 Guilford Pharmaceuticals Inc. Substituted ethyl α,α-diarylmethyl ether derivatives
US6011035A (en) * 1998-06-30 2000-01-04 Neuromed Technologies Inc. Calcium channel blockers
ATE269848T1 (de) * 1999-04-07 2004-07-15 Univ Virginia Calciumkanalblocker als antikrebsmittel
US6946475B1 (en) 1999-04-07 2005-09-20 University Of Virginia Patent Foundation Anticancer calcium channel blockers
EP1406624A4 (de) * 2001-06-13 2005-03-30 Teva Pharma Verfahren zur herstellung von paroxetin, das im wesentlichen frei von alkoxyverunreinigungen ist
KR101821343B1 (ko) 2010-03-01 2018-01-23 타우 쎄라퓨틱스 엘엘씨 암 진단 및 영상화

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1545094A (en) * 1976-12-14 1979-05-02 Gist Brocades Nv Piperazine derivatives

Also Published As

Publication number Publication date
TNSN89103A1 (fr) 1991-02-04
FR2636946A1 (fr) 1990-03-30
CZ540989A3 (en) 1994-11-16
DD284875A5 (de) 1990-11-28
SU1757462A3 (ru) 1992-08-23
DE68912860T2 (de) 1994-08-11
MA21631A1 (fr) 1990-04-01
JPH02121964A (ja) 1990-05-09
PT91783A (pt) 1990-03-30
IL91689A0 (en) 1990-06-10
HUT52049A (en) 1990-06-28
DE68912860D1 (de) 1994-03-17
AR246255A1 (es) 1994-07-29
PT91783B (pt) 1995-08-09
EP0360685B1 (de) 1994-02-02
IE63648B1 (en) 1995-05-31
OA09135A (fr) 1991-10-31
ES2062071T3 (es) 1994-12-16
HU208422B (en) 1993-10-28
EP0360685A1 (de) 1990-03-28
IE893050L (en) 1990-03-23
ZA897212B (en) 1991-03-27
NZ230744A (en) 1991-06-25
CA1327364C (fr) 1994-03-01
US4957927A (en) 1990-09-18
NO893764D0 (no) 1989-09-22
DK468389D0 (da) 1989-09-22
YU170189A (en) 1991-02-28
AU4169089A (en) 1990-03-29
DK468389A (da) 1990-03-24
FR2636946B1 (fr) 1990-11-02
AU617530B2 (en) 1991-11-28
NO893764L (no) 1990-03-26
CZ279282B6 (cs) 1995-04-12

Similar Documents

Publication Publication Date Title
DE19475025I2 (de) Dialkoxypyridine, Verfahren zu ihrer Herstellung, ihre Anwendung und sie enthaltende Arzneimittel.
ATE84040T1 (de) Phenol-substituierte gem-diphosphonat-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
PT84078A (de) Dyarylalkyl-substituierte alkylamine verfahren zu ihrer herstellung ihre verwendung sowie sie enthaltende arzneimittel
ATE9803T1 (de) 7-amino-1-cyclopropyl-4-oxo-1,4dihydronaphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung und sie enthaltende arzneimittel.
DE19375046I2 (de) 1,2,3,9-Tetrahydro-3-Ä(1H-imidazol-1-yl)methylÜ-4H-carbazol-4-one Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
ATE53211T1 (de) Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung.
DE68904364D1 (de) (aza)naphtalensultam-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.
ATE101132T1 (de) 1-((diarylmethoxy)alkyl>-pyrrolidine und piperidine, verfahren zu ihrer herstellung und arzneimittel, die sie enthalten.
DE3484925D1 (de) Pyrazolochinoline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DE3767789D1 (de) Substituierte aminodihydrooxazole, -thiazole und -imidazole, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
DE3576686D1 (de) Chinolinone, verfahren zu ihrer herstellung und die sie enthaltenden pharmazeutischen praeparate.
DE3483308D1 (de) Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DE68903425D1 (de) Verbindungen mit zentraler analgetischer verwendung, verfahren zu ihrer herstellung und arzneimittel die sie enthalten.
ATE10094T1 (de) 3,4-bis-substituierte 1,2,5-oxadiazol-2-oxide, verfahren zu ihrer herstellung, und sie enthaltende pharmazeutische zubereitungen.
DE3579602D1 (de) 1h-imidazol-derivate, ein verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATA146488A (de) 2-methoxymethylpenemverbindungen, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
DE3883164D1 (de) Rhodanin-derivate, verfahren zu ihrer herstellung, ihre anwendung und pharmazeutische zusammensetzungen, die sie enthalten.
DE3889043D1 (de) N-(substituiertes Alkyliden)-1,2,3,4-tetrahydro-9-acridinamine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
DE69220389D1 (de) Tetrahydroisoquinolinderivate, Verfahren zu deren Herstellung und fungizide Mittel die sie enthalten
ATE3976T1 (de) Substituierte 3-(1-pyrrolidinyl)-5-sulfamoylbenzoes[ure-derivate, verfahren zu ihrer herstellung, pharmazeutische zubereitungen, die sie enthalten und verfahren zu deren herstellung.
DE3484583D1 (de) Pyrimido(4,5-g)chinoline, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zubereitungen.
DE69107274D1 (de) Phenoxyessigsäure-Derivate, Verfahren zu ihrer Herstellung, und pharmazeutische Zusammensetzungen die sie enthalten.
ATE87310T1 (de) 2-imino-benzothiazolin-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.
DE68914500D1 (de) Alkylarylsulfone und Verfahren zu ihrer Herstellung.
ATE84529T1 (de) (aza)naphtalensultam-derivate, verfahren zu deren herstellung und arzneimittel, die sie enthalten.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee